|
Morrison, S A; Pearson, S L; Steigbigel, R T (1998) Anti-F(ab')2 antibody in HIV type 1 infection: relationship to hypergammaglobulinemia and to antibody specific to the V3 loop region of glycoprotein 120. AIDS Res Hum Retroviruses 14:491-8
|
|
Handley, M A; Steigbigel, R T; Morrison, S A (1996) A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages. J Virol 70:4451-6
|
|
Moorjani, H; Craddock, B P; Morrison, S A et al. (1996) Impairment of phagosome-lysosome fusion in HIV-1-infected macrophages. J Acquir Immune Defic Syndr Hum Retrovirol 13:18-22
|
|
Maruenda, H; Johnson, F (1995) Design and synthesis of novel inhibitors of HIV-1 reverse transcriptase. J Med Chem 38:2145-51
|
|
Tyagi, S C; Simon, S R; Carter, C A (1994) Effect of pH and nonphysiological salt concentrations on human immunodeficiency virus-1 protease dimerization. Biochem Cell Biol 72:175-81
|
|
Zybarth, G; Krausslich, H G; Partin, K et al. (1994) Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain. J Virol 68:240-50
|
|
Carter, C; Zybarth, G (1994) Processing of retroviral Gag polyproteins: an in vitro approach. Methods Enzymol 241:227-53
|
|
Ehrlich, L S; Agresta, B E; Gelfand, C A et al. (1994) Spectral analysis and tryptic susceptibility as probes of HIV-1 capsid protein structure. Virology 204:515-25
|
|
Suzuki, K; Craddock, B P; Kano, T et al. (1993) Colorimetric reverse transcriptase assay for HIV-1. J Virol Methods 41:21-8
|
|
Tyagi, S C; Carter, C A (1992) Continuous assay of the hydrolytic activity of human immunodeficiency virus-1 protease. Anal Biochem 200:143-8
|
Showing the most recent 10 out of 23 publications
